Most recent 12 month Revenue for Javelin Pharmaceuticals Increased by 555.81% as reported by T12-NEWS
Stock Quote:(N/A:JAV)
11/17/2009
0.00
N/A
N/A
0
Most recent 12 month Revenue for Javelin Pharmaceuticals Increased by 555.81% as reported by T12-NEWS
Last
Price Change
% Chg
Volume
New York, NY, November 17, 2009,T12-NEWS reports that Revenue for Javelin Pharmaceuticals (AMEX:JAV) for its trailing twelve months (TTM) ended September 30, 2009 was $4,009,282, a 555.81% increase ov ... read full story
Stocks ended flat and closed July with the strongest monthly gains in a year. The markets were volatile throughout the session following mixed economic data earlier. Recovery concerns were renewed after GDP growth slowed in Q2, but Chicago PMI jumped ... read full story